Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Macy's, Inc. stock logo
M
Macy's
$13.94
+1.6%
$14.85
$12.60
$22.10
$3.87B2.077.23 million shs7.35 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.73
-1.0%
$26.28
$24.48
$31.54
$145.79B0.6140.13 million shs37.26 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Macy's, Inc. stock logo
M
Macy's
+1.69%+4.41%-4.06%-14.48%-33.21%
Pfizer Inc. stock logo
PFE
Pfizer
-1.05%-0.78%-0.54%+1.40%-8.16%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Macy's, Inc. stock logo
M
Macy's
3.9662 of 5 stars
3.12.03.31.12.21.71.3
Pfizer Inc. stock logo
PFE
Pfizer
4.8876 of 5 stars
2.33.04.24.22.83.33.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Macy's, Inc. stock logo
M
Macy's
2.15
Hold$15.5611.63% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.50
Moderate Buy$31.9224.09% Upside

Current Analyst Ratings Breakdown

Latest M and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/10/2025
Macy's, Inc. stock logo
M
Macy's
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$14.00
3/7/2025
Macy's, Inc. stock logo
M
Macy's
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$15.00
3/7/2025
Macy's, Inc. stock logo
M
Macy's
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/7/2025
Macy's, Inc. stock logo
M
Macy's
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $14.00
3/7/2025
Macy's, Inc. stock logo
M
Macy's
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$19.00 ➝ $17.00
3/7/2025
Macy's, Inc. stock logo
M
Macy's
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$9.00 ➝ $8.00
3/6/2025
Macy's, Inc. stock logo
M
Macy's
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$19.00 ➝ $14.00
3/6/2025
Macy's, Inc. stock logo
M
Macy's
Gordon Haskett
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeAccumulate ➝ Hold
3/6/2025
Macy's, Inc. stock logo
M
Macy's
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform$17.00 ➝ $17.00
2/27/2025
Macy's, Inc. stock logo
M
Macy's
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform$17.00 ➝ $17.00
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Macy's, Inc. stock logo
M
Macy's
$23.01B0.17$6.06 per share2.30$15.10 per share0.92
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.03 per share6.38$15.81 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Macy's, Inc. stock logo
M
Macy's
$105M$2.0623.625.71N/A0.73%21.99%5.60%5/20/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.248.490.6412.62%19.47%8.09%4/29/2025 (Estimated)

Latest M and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/6/2025Q4 2025
Macy's, Inc. stock logo
M
Macy's
$1.55$1.80+$0.25$1.21$7.76 billion$7.77 billion
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Macy's, Inc. stock logo
M
Macy's
$0.735.24%+32.31%35.44%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.69%+2.50%121.99%16 Years

Latest M and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/28/2025
Macy's, Inc. stock logo
M
Macy's
quarterly$0.18245.16%3/14/20253/14/20254/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Macy's, Inc. stock logo
M
Macy's
0.67
1.26
0.17
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73

Institutional Ownership

CompanyInstitutional Ownership
Macy's, Inc. stock logo
M
Macy's
87.36%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Macy's, Inc. stock logo
M
Macy's
2.77%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Macy's, Inc. stock logo
M
Macy's
85,581277.64 million269.95 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable

Recent News About These Companies

Guggenheim Reaffirms Their Buy Rating on Pfizer (PFE)
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Shares Down 1.5% - Here's Why
Pfizer Inc. stock logo
Guggenheim Reiterates "Buy" Rating for Pfizer (NYSE:PFE)
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by AGF Management Ltd.
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Trading Down 1.8% - What's Next?
Arvinas, Pfizer Report Positive Phase 3 VERITAC-2 Results
Pfizer: Undervalued Safe Haven In Risk-Off Market​
Pfizer: Undervalued Safe Haven In Risk-Off Market​

New MarketBeat Followers Over Time

Media Sentiment Over Time

Macy's stock logo

Macy's NYSE:M

$13.94 +0.23 (+1.64%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$13.94 +0.01 (+0.07%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Pfizer stock logo

Pfizer NYSE:PFE

$25.72 -0.27 (-1.02%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$25.76 +0.03 (+0.12%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.